Skip to main content

Peer Review reports

From: A randomized, double blind, cross-over, placebo-controlled clinical trial to assess the effects of Candesartan on the insulin sensitivity on non diabetic, non hypertense subjects with dysglyce mia and abdominal obesity. "ARAMIA"

Original Submission
24 Aug 2006 Submitted Original manuscript
25 Aug 2006 Author responded Author comments - Patricio López-Jaramillo
Resubmission - Version 2
25 Aug 2006 Submitted Manuscript version 2
Publishing
7 Sep 2006 Editorially accepted
7 Sep 2006 Article published 10.1186/1745-6215-7-28

You can find further information about peer review here.

Back to article page

Trials

ISSN: 1745-6215